Population response to information on reversibility of type 2 diabetes

Diabetic Medicine

Volumn 30, Issue 4, 2013, Pages e135-e138

  Steven, Sarah ^a   Lim, E L ^a   Taylor, R ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; SULFONYLUREA; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BODY WEIGHT LOSS; CAPILLARY BLOOD; DISEASE DURATION; E-MAIL; FASTING; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFORMATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SELF REPORT; BLOOD; CALORIC RESTRICTION; DIET THERAPY; METABOLISM; MIDDLE AGED; PATIENT EDUCATION; PHYSIOLOGY; TIME; TREATMENT OUTCOME; WEIGHT REDUCTION;

BLOOD GLUCOSE; CALORIC RESTRICTION; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; SELF REPORT; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84874126045     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12116     Document Type: Article

References (10)

1. Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes is associated with decrease in pancreas and liver fat. Diabetologia 2011; 54: 2506–2514.
2. Taylor R. Reversing Type 2 Diabetes. 2011. Available at http://www.ncl.ac.uk/magres/research/diabetes/reversal.htm Last accessed 7 July 2011.
3. International Federation of Clinical Chemistry. IFCC recommendation on reporting results for blood glucose. Clin Chim Acta 2001; 307: 205–209.
4. UK Prospective Diabetes Study. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1999; 352: 837–853.
5. Hall TC, Pellen MGC, Sedman PC, Jain PK. Preoperative factors predicting remission of Type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg 2010; 20: 1245–1250.
6. Paisey RB, Frost J, Harvey P, Paisey A, Bower L, Paisey RM et al. Five-year results of a prospective very low calorie diet or conventional weight loss programme in type 2 diabetes. J Hum Nutr Diet 2002; 15: 121–127.
7. Ross HM, Laws R, Reckless J, Lean M, Counterweight Project T. Evaluation of the Counterweight Programme for obesity management in primary care: a starting point for continuous improvement. Br J Gen Pract 2008; 58: 548–554.
8. Low CC, Grossman EB, Gumbiner B. Potentiation of effects of weight loss by monounsaturated fatty acids in obese NIDDM patients. Diabetes 1996; 45: 569–575.
9. National Institute for Health and Clinical Excellence. National Collaborating Centre for Chronic Conditions: Type 2 Diabetes: National Clinical Guideline for Management in Primary and Secondary Care. NICE-CG66 (update). London: Royal College of Physicians, 2008.
10. Taylor R. Pathogenesis of Type 2 diabetes: tracing the reverse route from cure to cause. Diabetologia 2008; 51: 1781–1789.